Characterisation of epitopes of pan-IgG/anti-G3m(u) and anti-Fc monoclonal antibodies. 2003

Paul N Nelson, and Olwyn M R Westwood, and Andy Soltys, and Roy Jefferis, and Margaret Goodall, and Karl R N Baumforth, and Geoff Frampton, and Gordon Tribbick, and Denise Roden, and Frank C Hay
Molecular Immunology Research Group, Division of Biomedical Sciences, University of Wolverhampton, Wulfruna Street, Wolverhampton, WV1 1SB, UK. p.n.nelson@wlv.ac.uk

The characterisation of monoclonal antibodies (MAbs) and their epitopes is important prior to their application as molecular probes. In this study, Western blotting using IgG1 Fc and pFc' fragments was employed to screen seven MAbs before pepscan analysis to determine their reactivity to potentially linear epitopes. MAbs PNF69C, PNF110A, X1A11 and MAbs WC2, G7C, JD312, 1A1 detected epitopes within the C(H)3 and C(H)2 domains, respectively. However, only four MAbs showed pepscan profiles that highlighted likely target residues. In particular, MAbs PNF69C and PNF110A that have previously been characterised with pan-IgG and anti-G3m(u) specificity, detected the peptide motif 338-KAKGQPR-344 which was located within the N-terminal region of the C(H)3 domain. Furthermore the majority of residues were present in all four IgG subclasses. Consequently the peptide identified was consistent with the pan-IgG nature of these antibodies. By using PCImdad, a molecular display programme, this sequence was visualised as surface accessible, located in the C(H)2/C(H)3 inter-domain region and proximal to the residue arginine(435). It is speculated that this residue may be important for phenotypic expression of G3m(u) and specificity of these reagents. Pepscan analysis of MAbs G7C and JD312 (both pan-IgG) highlighted the core peptide sequence 290-KPREE-294, which was present in the C(H)2 domain and was common to all four IgG subclasses. PCImdad also showed this region to be highly accessible and was consistent with previous bioinformatic and autoimmune analysis of IgG. Overall these MAbs may serve as useful anti-IgG or anti-G3m(u) reagents and probes of immunoglobulin structure.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007141 Immunoglobulin Fc Fragments Crystallizable fragments composed of the carboxy-terminal halves of both IMMUNOGLOBULIN HEAVY CHAINS linked to each other by disulfide bonds. Fc fragments contain the carboxy-terminal parts of the heavy chain constant regions that are responsible for the effector functions of an immunoglobulin (COMPLEMENT fixation, binding to the cell membrane via FC RECEPTORS, and placental transport). This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN. Fc Fragment,Fc Fragments,Fc Immunoglobulin,Fc Immunoglobulins,Ig Fc Fragments,Immunoglobulin Fc Fragment,Immunoglobulins, Fc,Immunoglobulins, Fc Fragment,Fc Fragment Immunoglobulins,Fc Fragment, Immunoglobulin,Fc Fragments, Ig,Fc Fragments, Immunoglobulin,Fragment Immunoglobulins, Fc,Fragment, Fc,Fragments, Ig Fc,Immunoglobulin, Fc
D007143 Immunoglobulin Heavy Chains The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa. Immunoglobulins, Heavy-Chain,Heavy-Chain Immunoglobulins,Ig Heavy Chains,Immunoglobulin Heavy Chain,Immunoglobulin Heavy Chain Subgroup VH-I,Immunoglobulin Heavy Chain Subgroup VH-III,Heavy Chain Immunoglobulins,Heavy Chain, Immunoglobulin,Heavy Chains, Ig,Heavy Chains, Immunoglobulin,Immunoglobulin Heavy Chain Subgroup VH I,Immunoglobulin Heavy Chain Subgroup VH III,Immunoglobulins, Heavy Chain
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006385 Hemagglutination Inhibition Tests Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination. Hemagglutination Inhibition Test,Inhibition Test, Hemagglutination,Inhibition Tests, Hemagglutination,Test, Hemagglutination Inhibition,Tests, Hemagglutination Inhibition
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000888 Antibodies, Anti-Idiotypic Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies. Anti-Antibodies,Anti-Idiotype Antibodies,Antibodies, Internal Image,Antigamma Globulin Antibodies,Antiglobulins,Anti Antibodies,Anti-gamma Globulin Antibodies,Anti Idiotype Antibodies,Anti gamma Globulin Antibodies,Anti-Idiotypic Antibodies,Antibodies, Anti,Antibodies, Anti Idiotypic,Antibodies, Anti-Idiotype,Antibodies, Anti-gamma Globulin,Antibodies, Antigamma Globulin,Globulin Antibodies, Anti-gamma,Globulin Antibodies, Antigamma,Image Antibodies, Internal,Internal Image Antibodies
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000915 Antibody Affinity A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of "avidity," which refers to the strength of the antigen-antibody bond after formation of reversible complexes. Affinity, Antibody,Antibody Avidity,Avidity, Antibody,Affinities, Antibody,Antibody Affinities,Antibody Avidities,Avidities, Antibody

Related Publications

Paul N Nelson, and Olwyn M R Westwood, and Andy Soltys, and Roy Jefferis, and Margaret Goodall, and Karl R N Baumforth, and Geoff Frampton, and Gordon Tribbick, and Denise Roden, and Frank C Hay
January 1994, Immunological investigations,
Paul N Nelson, and Olwyn M R Westwood, and Andy Soltys, and Roy Jefferis, and Margaret Goodall, and Karl R N Baumforth, and Geoff Frampton, and Gordon Tribbick, and Denise Roden, and Frank C Hay
January 2000, Veterinary immunology and immunopathology,
Paul N Nelson, and Olwyn M R Westwood, and Andy Soltys, and Roy Jefferis, and Margaret Goodall, and Karl R N Baumforth, and Geoff Frampton, and Gordon Tribbick, and Denise Roden, and Frank C Hay
January 1989, Experimental and clinical immunogenetics,
Paul N Nelson, and Olwyn M R Westwood, and Andy Soltys, and Roy Jefferis, and Margaret Goodall, and Karl R N Baumforth, and Geoff Frampton, and Gordon Tribbick, and Denise Roden, and Frank C Hay
July 1982, Nature,
Paul N Nelson, and Olwyn M R Westwood, and Andy Soltys, and Roy Jefferis, and Margaret Goodall, and Karl R N Baumforth, and Geoff Frampton, and Gordon Tribbick, and Denise Roden, and Frank C Hay
October 2012, Avicenna journal of medical biotechnology,
Paul N Nelson, and Olwyn M R Westwood, and Andy Soltys, and Roy Jefferis, and Margaret Goodall, and Karl R N Baumforth, and Geoff Frampton, and Gordon Tribbick, and Denise Roden, and Frank C Hay
December 1987, Revue francaise de transfusion et immuno-hematologie,
Paul N Nelson, and Olwyn M R Westwood, and Andy Soltys, and Roy Jefferis, and Margaret Goodall, and Karl R N Baumforth, and Geoff Frampton, and Gordon Tribbick, and Denise Roden, and Frank C Hay
April 1990, Forensic science international,
Paul N Nelson, and Olwyn M R Westwood, and Andy Soltys, and Roy Jefferis, and Margaret Goodall, and Karl R N Baumforth, and Geoff Frampton, and Gordon Tribbick, and Denise Roden, and Frank C Hay
January 1989, Journal of immunological methods,
Paul N Nelson, and Olwyn M R Westwood, and Andy Soltys, and Roy Jefferis, and Margaret Goodall, and Karl R N Baumforth, and Geoff Frampton, and Gordon Tribbick, and Denise Roden, and Frank C Hay
April 1984, Nihon hoigaku zasshi = The Japanese journal of legal medicine,
Paul N Nelson, and Olwyn M R Westwood, and Andy Soltys, and Roy Jefferis, and Margaret Goodall, and Karl R N Baumforth, and Geoff Frampton, and Gordon Tribbick, and Denise Roden, and Frank C Hay
November 1986, Journal of medical microbiology,
Copied contents to your clipboard!